These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 19758107)

  • 1. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E; Zampeli E; Sander K; Stark H
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine H4 receptor ligands and their potential therapeutic applications.
    Kiss R; Keseru GM
    Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine receptors in the CNS as targets for therapeutic intervention.
    Passani MB; Blandina P
    Trends Pharmacol Sci; 2011 Apr; 32(4):242-9. PubMed ID: 21324537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
    Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
    Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major advances in the development of histamine H4 receptor ligands.
    Smits RA; Leurs R; de Esch IJ
    Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H4 receptor ligands and their potential therapeutic applications: an update.
    Kiss R; Keserű GM
    Expert Opin Ther Pat; 2012 Mar; 22(3):205-21. PubMed ID: 22385042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine.
    Bäumer W; Wendorff S; Gutzmer R; Werfel T; Dijkstra D; Chazot P; Stark H; Kietzmann M
    Allergy; 2008 Oct; 63(10):1387-94. PubMed ID: 18782117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
    Medina V; Croci M; Crescenti E; Mohamad N; Sanchez-Jiménez F; Massari N; Nuñez M; Cricco G; Martin G; Bergoc R; Rivera E
    Cancer Biol Ther; 2008 Jan; 7(1):28-35. PubMed ID: 17932461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.
    Kiss R; Keseru GM
    Expert Opin Ther Pat; 2014 Nov; 24(11):1185-97. PubMed ID: 25219452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family.
    Leurs R; Vischer HF; Wijtmans M; de Esch IJ
    Trends Pharmacol Sci; 2011 Apr; 32(4):250-7. PubMed ID: 21414671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
    Esbenshade TA; Fox GB; Cowart MD
    Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine pharmacology and new CNS drug targets.
    Tiligada E; Kyriakidis K; Chazot PL; Passani MB
    CNS Neurosci Ther; 2011 Dec; 17(6):620-8. PubMed ID: 22070192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists.
    Hancock AA
    Biochem Pharmacol; 2006 Apr; 71(8):1103-13. PubMed ID: 16513092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
    Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in histamine H3 receptor antagonists/inverse agonists.
    Łazewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.